Assessing the evolving I-O landscape: key challenges and opportunities for 2024

IMMUNO-ONCOLOGY INSIGHTS

Assessing the evolving I-O landscape: key challenges and opportunities for 2024

February 2024
Assessing the evolving I-O landscape: key challenges and opportunities for 2024
Download PDF

Foreword

New horizons for I-O in 2024: what the experts have to say

New horizons for I-O in 2024: what the experts have to say

Samik Upadhaya
7 March
Read

Commentary

Will it be possible to find predictive genetic markers of immune checkpoint inhibitor toxicity that are not also predictive of survival?

Will it be possible to find predictive genetic markers of immune checkpoint inhibitor toxicity that are not also predictive of survival?

Claire Palles, Ik Shin Chin
17 January
Read

Interview

Revolutionizing cancer treatment? A conversation on the potential of personalized cancer vaccines

Revolutionizing cancer treatment? A conversation on the potential of personalized cancer vaccines

Roy de Souza, David Hawke
20 March
Read
Navigating genomics and transcriptomics in the immuno-oncology space

Navigating genomics and transcriptomics in the immuno-oncology space

Katie Campbell
1 March
Read
The future of combination therapies in I-O: insights, challenges, & future endeavors

The future of combination therapies in I-O: insights, challenges, & future endeavors

Roy Baynes
10 January
Read